Biotech Startups

MetGen develops industrial enzymes for bio-based chemical and material production from biomass and wood feedstocks. The company provides enzyme solutions to biotechnology and chemical manufacturing companies seeking greener alternatives to petroleum-based production processes.

2 investors

Metly is an AI-native pharma intelligence platform that aggregates internal and external data to search regulatory filings, clinical databases, and partnership signals, monitor competitors, and automatically update intelligence workflows. It serves pharma and biotech teams for competitive intelligence, business development, licensing, market access, and asset diligence, pairing its platform with therapeutic-area experts.

2 investors

Metrion Biosciences provides ion channel screening and drug discovery services for pharmaceutical and biotech companies. The company specializes in preclinical contract research operations with over 100 years of combined team expertise in ion channel biology.

2 investors

Mewery is a foodtech venture developing cultivated meat with the stated aims of helping animals and the planet and changing how meat is produced and consumed. It positions itself around alternative/cultured meat technology.

2 investors

MFX develops the Cyto Engine, an automated bioprocessing platform that accelerates development and manufacturing of engineered cells for cell and gene therapy. The platform combines scalable bioprocessing with analytics and data tools to increase access to these therapies.

2 investors

Micro Meat develops technological solutions to increase production capacity for cultivated meat manufacturing.

2 investors

Prolific Earth Sciences develops microBIOMETER, an on-site soil health diagnostic test that measures microbial biomass and fungal-to-bacterial ratios to help growers and agricultural practitioners assess soil quality. The company serves regenerative agriculture and landscaping practitioners seeking rapid, affordable alternatives to costly laboratory testing.

2 investors

Microbiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease. The company uses a proprietary microbiome profiling platform based on clinical data to identify specific bacterial strains associated with patient benefit.

2 investors

MicroLub is a UK-based deep-tech ingredient company that develops protein-based biolubricant molecules — protein microgels coated with polysaccharides — that reduce molecular friction to replace fats and oils in food and personal care products while retaining their mouthfeel and texture. It sells bespoke formulation solutions to R&D teams at food manufacturers, ingredient companies, and personal care brands.

2 investors

The page promotes GARUDA4D, an online gambling platform offering slot games, live casino, digital table games, cockfighting, and fish shooting games. It is a gaming/betting website targeting players in Indonesia.

2 investors

miDiagnostics develops a portfolio of molecular diagnostic tests designed for rapid and accurate results to support healthcare professionals in clinical diagnosis and patient care.

2 investors

Mimetas provides microfluidic technology and services for 3D tissue culture research, offering pre-built tissue models, instrumentation, and platforms for pharmaceutical and safety testing applications.

2 investors

Mindera Health develops digital predictive skin analytics technology, described as Dermal Intelligence, aimed at improving health economic outcomes in dermatology. The company operates in the digital health and diagnostics space.

2 investors

MindMaze develops neurotherapeutic solutions combining behavioral therapy, software, devices, and data to treat and manage neurological disease and support brain health and recovery. Its precision neurotherapeutic products are used by patients and caregivers in clinical centers worldwide.

2 investors

Definium Therapeutics is a biotech company developing psychedelic-based treatments for brain health disorders, including formulations of LSD and MDMA enantiomers targeting depression, anxiety, PTSD, and autism spectrum disorder. Its pipeline focuses on psychiatric and neurological conditions affecting patients in the U.S.

2 investors

A Spanish-language blog that publishes articles on health and medicine topics, such as flu prevention and vaccination recommendations, for general readers.

2 investors

Mirror Physics offers Axon, a software product for drug discovery workflows that integrates with a team's existing tools, data, and infrastructure to surface insights and handle pipeline tasks. It targets drug discovery and pharmaceutical research teams.

2 investors

Mission BioCapital is a venture capital firm that invests in early-stage life science companies, from therapeutics and drug discovery to biotech tools and diagnostics. The firm provides capital, operational support, and lab infrastructure through its MBC BioLabs co-working spaces to help scientific entrepreneurs launch and scale biotech startups.

2 investors

Model Medicines is an AI-powered biotechnology company that uses computation to discover and engineer small molecule drugs targeting disease-driving biological mechanisms. The company has programs in infectious disease, oncology, and inflammation, with compounds in development including a broad-spectrum antiviral and a BRD4 inhibitor.

2 investors

Modulight develops a platform to treat severe neurological diseases through scientific innovation and clinical expertise.

2 investors

Modulus Therapeutics was a Seattle biotech spun out of the Allen Institute for AI that used machine learning to engineer immune cells, initially NK cells for cancer, later shifting toward autoimmune cell therapies.

2 investors

Mogrify is a biotechnology company developing in vivo cellular reprogramming therapies, using its proprietary MOGRIFY and epiMOGRIFY platforms that apply transcriptomic and epigenetic data to identify transcription factor combinations for converting one cell type into another. It targets diseases with high unmet clinical need, initially in otology, ophthalmology, and diabetes.

2 investors

A company that develops patented chemical formulations to control pest and vector populations through behavioral modification, serving applications in human health, agriculture, and livestock protection.

2 investors

Molecular Stethoscope (Superfluid) develops a cell-free messenger RNA (cf-mRNA) "liquid biopsy" blood-based diagnostic platform for detecting neurodegenerative diseases, currently focused on early-stage Alzheimer's disease. The minimally invasive approach aims to replace spinal taps and brain scans, enabling repeated monitoring of a patient's disease state to guide therapy.

2 investors